Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Eur J Med Res ; 26(1): 152, 2021 Dec 20.
Article in English | MEDLINE | ID: mdl-34930492

ABSTRACT

BACKGROUND: COVID-19 and its related anti-inflammatory treatment (steroids, immunomodulators) may induce the reactivation of latent bacterial, parasitic, and viral infections. According to our knowledge, no case of disseminated HHV-8-related Kaposi sarcoma (KS) after COVID-19 and its treatment has been described so far. Only one case of cutaneous KS concurrently with COVID-19 has been previously reported. CASE PRESENTATION: We describe a case of disseminated KS in a 61-year-old immunocompetent Albanian man after hospitalization for COVID-19. METHODS FOR LITERATURE RESEARCH: We used PubMed as biomedical database for the literature research. We selected keyword combinations including "Kaposi sarcoma," "HHV-8," "immunocompetent," "COVID-19," "SARS-CoV-2," and "steroids." No time or language limitation was set. Titles and abstracts of selected articles were systematically screened. Articles were included in the examination if they were published under free access through the digital library of the University of Brescia (Italy), and provided full text. Articles were excluded if the topic was beyond the aim of our study. Finally, we selected 15 articles. RESULTS: We describe a case of KS in COVID-19 patient and postulate that Interleukin-6 (IL-6) activity and steroid-induced immunodeficiency may play a major role in KS emergence. No published case of disseminated KS following COVID-19 in otherwise healthy individuals was found through the systematic literature review, despite the high incidence of COVID-19 in areas with medium-high prevalence of HHV-8 infection. This observation might be explained by the role of individual genetic susceptibility factors. CONCLUSIONS: SARS-CoV-2 infection and its treatment may lead to reactivation of several latent infections, including HHV-8 and its related clinical syndrome, Kaposi sarcoma.


Subject(s)
COVID-19/genetics , SARS-CoV-2/genetics , Sarcoma, Kaposi/drug therapy , COVID-19/diagnosis , Databases, Chemical , Humans , Interleukin-6/metabolism , Language , Male , Middle Aged , SARS-CoV-2/drug effects , SARS-CoV-2/pathogenicity , Sarcoma, Kaposi/complications , Sarcoma, Kaposi/genetics , COVID-19 Drug Treatment
2.
Travel Med Infect Dis ; 44: 102196, 2021.
Article in English | MEDLINE | ID: mdl-34748988

ABSTRACT

BACKGROUND: Severe imported pediatric malaria is of concern in non-endemic settings. We aimed to determine the features of pediatric severe cases in order to design a model able to stratify patients at presentation. METHODS: We conducted a retrospective cross-sectional study including all imported P. falciparum malaria infection in patients ≤14 years of age, treated from January 2008 to February 2019 in two tertiary hospitals: Brescia, Italy and Barcelona, Spain. Severe malaria was defined according to World Health Organization criteria. Mortality rate, pediatric intensive care unit (PICU) stay and blood transfusion were analysed as adverse outcomes. RESULTS: Out of 139 children included, 30.9% were severe malaria. Twenty-seven (19.4%) were admitted to PICU, and transfusion was required in 14 cases (10.1%). Predictors for severe malaria were: young age, low hemoglobin, high white blood cells (WBC) and high C-reactive protein. Platelet <130,000/µl correlated with severe malaria (without statistical significance). A model that includes age, WBC and C-reactive protein shows a high specificity to classify patients without severe malaria (92.3%) with 70% PPV and 75% NPV. CONCLUSIONS: A score based on patient's age, WBC and C-reactive protein easily available at emergency room can help to identify children with higher risk of adverse outcomes.


Subject(s)
Antimalarials , Communicable Diseases, Imported , Malaria, Falciparum , Antimalarials/therapeutic use , Child , Cross-Sectional Studies , Humans , Malaria, Falciparum/diagnosis , Malaria, Falciparum/drug therapy , Malaria, Falciparum/epidemiology , Plasmodium falciparum , Retrospective Studies , Risk Assessment , Travel
5.
J Travel Med ; 27(1)2020 Feb 03.
Article in English | MEDLINE | ID: mdl-31616948

ABSTRACT

BACKGROUND: Barriers to access to care, different diagnostic strategies and low awareness remain challenging issues in the fight against schistosomiasis.Our study aims to examine management of schistosomiasis in migrants attending large tertiary hospitals in Italy, in order to call for a comprehensive approach. METHODS: A retrospective review of schistosomiasis cases was carried out between January 1, 2016, and December 31, 2017, in five large Infectious Disease Centers in Italy. We included all patients diagnosed with schistosomiasis. We differentiated among (i) asymptomatic patients diagnosed by serology either as healthy 'migrant evaluation' or as 'late evaluation' in patients followed because of a different infection and (ii) patients tested because of a suggestive clinical presentation. Patients characteristics and clinical data were recorded. RESULTS: One hundred forty-nine patients were included, 137 (91.9%) were male, the median age was 26 years and 70% of them came from Sub-Saharan Africa.Thirty-eight asymptomatic patients (25.5%) were diagnosed by serology [15, (10.1%) among 'migrant evaluation' and 23 (15.4%) among 'late evaluation' group], and 111 (74.5%) presented with signs/symptoms.The median diagnostic delay from arrival in Italy was 31 months: 110 for asymptomatic group and 16 months for symptomatic patients. Among the 111 symptomatic patients, 41 individuals were already followed in our clinics, and they never underwent screening before appearance of evident disease. Among patients with positive serology who were tested by microscopy, 32/86 (37.2%) had confirmed diagnosis. Forty-five (37.8%) patients presented radiologic abnormalities. Praziquantel was the treatment of choice (70.1% for 3 days and 29.9% in a single-day dose), and 77 (51.7%) were lost to follow-up. CONCLUSIONS: In our centers, a high proportion of patients were tested late after arrival, and most of them presented with clinical apparent disease. Well-defined strategies and implementation of recent guidelines are needed to improve early diagnosis and to overcome heterogeneity of practice.


Subject(s)
Mass Screening/methods , Schistosomiasis/diagnosis , Transients and Migrants/statistics & numerical data , Adult , Anthelmintics/therapeutic use , Delayed Diagnosis/prevention & control , Enzyme-Linked Immunosorbent Assay , Female , Humans , Italy , Male , Praziquantel/therapeutic use , Retrospective Studies , Schistosomiasis/drug therapy , Travel
6.
Infection ; 47(6): 1059-1063, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31321641

ABSTRACT

Non-typhoidal Salmonella (NTS) spp. causes about 40% of all infective aortitis and it is characterized by high morbidity and mortality. Human infection occurs by fecal-oral transmission through ingestion of contaminated food, milk, or water (inter-human or zoonotic transmission). Approximately 5% of patients with NTS gastroenteritis develop bacteremia and the incidence of extra-intestinal focal infection in NTS bacteremia is about 40%. The organism can reach an extra-intestinal focus through blood dissemination, direct extension from the surrounding organs and direct bacterial inoculation (e.g. invasive medical procedures). Medical and surgical interventions are both needed to successfully control the infection. Here, we report a case of abdominal sub-renal aortitis caused by Salmonella enterica serovar Enteritidis in an 80-year-old man.


Subject(s)
Aorta, Abdominal/surgery , Aortitis/diagnosis , Salmonella Infections/diagnosis , Salmonella enteritidis/isolation & purification , Aged, 80 and over , Aorta, Abdominal/pathology , Aortitis/microbiology , Aortitis/pathology , Aortitis/surgery , Humans , Italy , Male , Salmonella Infections/microbiology , Salmonella Infections/pathology , Salmonella Infections/surgery , Treatment Outcome
7.
Infection ; 47(3): 461-462, 2019 06.
Article in English | MEDLINE | ID: mdl-30830600

ABSTRACT

The original version of this article unfortunately contained a mistake. The given name and family name of Filippo Parretti was transposed in the original publication. The correct name is as shown above.

8.
Infection ; 47(3): 447-459, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30666616

ABSTRACT

OBJECTIVES: To evaluate ultrasound and praziquantel to, respectively, assess and reduce urogenital schistosomiasis (UGS)-associated morbidity in migrants from Sub-Saharan Africa (SSA). METHODS: Migrants from SSA with UGS attending three Italian centres for tropical diseases during 2011-2016 were retrospectively enrolled. Data on clinical symptoms, routine laboratory, parasitological tests, and ultrasound reported as per the WHO-Niamey protocol were collected at baseline and at available follow-up visits after treatment with praziquantel 40 mg/kg/day for 3 days. RESULTS: One hundred and seventy patients with UGS were enrolled and treated with praziquantel. Baseline ultrasonography showed urinary tract abnormalities in 115/169 patients (68%); the mean global Schistosoma haematobium score was 2.29 (SD 2.84, IQR 0-2), the mean urinary bladder intermediate score 1.75 (SD 1.73, IQR 0-2), and the mean upper urinary tract intermediate score 0.54 (SD 2.37, IQR 1-10). Abnormalities were more common among the 111 (65%) who were symptomatic (p < 0.02; OR 2.53; 95% CI 1.19-5.35). Symptoms started in 94/111 (85%) before arriving (median 63 months, IQR 12-119). At follow-up, we observed a significant reduction in the prevalence of UGS-related symptoms, blood, urine, and ultrasound abnormalities. CONCLUSIONS: Our study results support the use of ultrasound and praziquantel for assessing and reducing UGS-associated morbidity in migrants. Health-seeking behaviour, diagnostic, and treatment delays contribute to the advanced pathology and qualified treatment success. To ensure earlier treatment, based on our findings, clinical experience, and available literature, we propose an algorithm for the diagnosis and clinical management of UGS. Multicentre studies are needed to improve the management of subjects with UGS in non-endemic countries.


Subject(s)
Emigrants and Immigrants , Schistosomiasis haematobia/diagnosis , Schistosomiasis haematobia/drug therapy , Adolescent , Adult , Africa South of the Sahara/ethnology , Aged , Animals , Cohort Studies , Emigrants and Immigrants/statistics & numerical data , Female , Humans , Italy/epidemiology , Male , Middle Aged , Prevalence , Retrospective Studies , Schistosoma haematobium , Schistosomiasis haematobia/epidemiology , Young Adult
11.
J Travel Med ; 25(1)2018 Jan 01.
Article in English | MEDLINE | ID: mdl-29232457

ABSTRACT

BACKGROUND: Even though malaria incidence is decreasing worldwide, travel-related cases reported in Europe have remained stable in recent years. In Italy, incidence had increased in the 1990s, reaching a peak in 1999; a slow decline was then reported over the subsequent decade. To our knowledge, few published data are available on imported malaria in Italy since 2010. In this article we aimed to analyse trends in imported malaria in the teaching hospital of Brescia, northern Italy, over the last 18 years. METHODS: All malaria cases diagnosed from 1999 to 2016 in Spedali Civili Hospital, Brescia, were retrospectively identified. Demographic, clinical and travel-related data were described. RESULTS: A total of 1200 cases of imported malaria were diagnosed in Brescia during the study period. Among them, 225 were children. A trend of increasing paediatric cases was identified over the study period, while cases in adults were stable. Most cases were diagnosed between August and October. Patients were most likely exposed in sub-Saharan Africa (87.2%). The main reported travel reason was travelling to visit friends and relatives (66.0%). A significantly higher risk of severe malaria was observed in non-immune patients and children visiting friend and relatives (P < 0.001 and P = 0.006, respectively). CONCLUSIONS: Our study reveals a relatively stable incidence in imported malaria cases with a peak during the summertime. A large and increasing paediatric burden of disease was identified. Imported malaria requires attention since in Italy a potential reappearance of autochthonous Plasmodium vivax malaria transmission cannot be excluded. Preventive action and physician awareness should be especially directed to children visiting friends and relatives in endemic countries and to non-immune patients since they both represent high-risk groups for severe malaria.


Subject(s)
Malaria/epidemiology , Travel , Adolescent , Adult , Africa South of the Sahara/ethnology , Aged , Aged, 80 and over , Antimalarials , Child , Child, Preschool , Female , Hospitals, Teaching , Humans , Incidence , India/ethnology , Infant , Infant, Newborn , Italy/epidemiology , Malaria/blood , Malaria/ethnology , Malaria/prevention & control , Male , Middle Aged , Pakistan/ethnology , Retrospective Studies , Young Adult
12.
Mediterr J Hematol Infect Dis ; 9(1): e2017023, 2017.
Article in English | MEDLINE | ID: mdl-28293411

ABSTRACT

The protective role of Sickle Cell Trait (SCT) in malaria endemic areas has been proved, and prevalence of HbS gene in malaria endemic areas is high. Splenic infarction is a well-known complication of SCT, while the association with malaria is considered rare. A Nigerian boy was admitted to our ward after returning from his country of origin, for P. falciparum malaria. He underwent abdominal ultrasound for upper right abdominal pain, showing cholecystitis and multiple splenic lesions suggestive of abscesses. Empiric antibiotic therapy was undertaken. Bartonella, Echinococcus, Entamoeba serologies, blood cultures, Quantiferon test, copro-parasitologic exam were negative; endocarditis was excluded. He underwent further blood exams and abdomen MRI, confirming the presence of signal alterations areas, with radiographic appearance of recent post-infarction outcomes. Hemoglobin electrophoresis showed a percentage of HbS of 40.6% and a diagnosis of SCT was then made. Splenic infarction should be taken into account in patients with malaria and localized abdominal pain. Moreover, diagnosis of SCT should be considered.

13.
Infection ; 45(3): 373-376, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28161771

ABSTRACT

INTRODUCTION: Due to the increasing number of refugees from East Africa, louse-borne relapsing fever (LBRF) has become an emergent disease in Europe. No single case of LBRF has been reported in Europe in refugees from other parts of Africa. CASE REPORT: We report a case of LBRF in a refugee from Mali, likely acquired in Libya, where several migration routes into Europe meet. The disease must be considered in any febrile refugee regardless the country of origin.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Pediculus/microbiology , Refugees , Relapsing Fever/diagnosis , Relapsing Fever/drug therapy , Amikacin/therapeutic use , Animals , Borrelia/genetics , Borrelia/isolation & purification , Borrelia/physiology , Ceftriaxone/therapeutic use , DNA, Bacterial/analysis , Doxycycline/therapeutic use , Humans , Italy , Libya , Male , Mali , RNA, Ribosomal, 16S/analysis , Relapsing Fever/microbiology , Sequence Analysis, DNA , Treatment Outcome , Young Adult
14.
J Travel Med ; 22(4): 276-8, 2015.
Article in English | MEDLINE | ID: mdl-25884911

ABSTRACT

Rickettsia felis is an emerging spotted fever group pathogen that may be responsible for potentially life-threatening infections. A cosmopolitan distribution has been postulated though most human cases were observed in Africa and the Americas. We report an imported case from Nepal that occurred in an Italian tourist who presented with a 1-week history of fever, headache, nausea, vomiting, and a mild maculopapular rash 14 days after return.


Subject(s)
Ceftriaxone/administration & dosage , Doxycycline/administration & dosage , Rickettsia Infections , Rickettsia felis , Siphonaptera , Travel , Animals , Anti-Bacterial Agents/administration & dosage , Female , Humans , Immunologic Tests/methods , Italy/epidemiology , Middle Aged , Nepal/epidemiology , Rickettsia Infections/blood , Rickettsia Infections/diagnosis , Rickettsia Infections/drug therapy , Rickettsia Infections/etiology , Rickettsia Infections/physiopathology , Rickettsia felis/isolation & purification , Rickettsia felis/pathogenicity , Serologic Tests/methods , Treatment Outcome
15.
Eur J Gastroenterol Hepatol ; 26(10): 1181-5, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25014626

ABSTRACT

Whipple's disease is a rare systemic condition resulting from a chronic infection by Tropheryma whipplei. Clinical presentation can be widely heterogeneous, often leading to delayed diagnosis and treatment. Furthermore, little is known about the underlying pathogenic mechanisms, although several abnormalities in immune cell function have been observed. We describe the case of a 51-year-old woman presenting with dysphagia, odynophagia, long-lasting low-grade fever, and malabsorption syndrome who underwent an upper gastrointestinal endoscopy showing esophageal candidiasis. On the same occasion, duodenal biopsies were also performed, with evidence of mucosal infiltration of periodic acid-Schiff-positive and CD68+ foamy macrophages at microscopic examination. Such findings were suggestive of Whipple's disease, as also confirmed by molecular analysis by PCR for T. whipplei. No specific risk factors were identified in our patient that could explain the occurrence of an opportunistic infection such as candida esophagitis, thus leading to the hypothesis of a direct correlation with Whipple's disease. Interestingly, a Giardia lamblia coinfection was subsequently identified, which is consistent with an underlying immune deficit although still undefined.


Subject(s)
Candidiasis/microbiology , Coinfection , Esophagitis/microbiology , Giardia lamblia/isolation & purification , Giardiasis/parasitology , Whipple Disease/microbiology , Anti-Infective Agents/therapeutic use , Biopsy , Candidiasis/complications , Candidiasis/diagnosis , Candidiasis/drug therapy , Candidiasis/immunology , Esophagitis/complications , Esophagitis/diagnosis , Esophagitis/drug therapy , Esophagitis/immunology , Female , Giardia lamblia/immunology , Giardiasis/complications , Giardiasis/diagnosis , Giardiasis/drug therapy , Giardiasis/immunology , Humans , Immunocompromised Host , Immunohistochemistry , Middle Aged , Predictive Value of Tests , Proton Pump Inhibitors/therapeutic use , Risk Factors , Treatment Outcome , Whipple Disease/complications , Whipple Disease/diagnosis , Whipple Disease/drug therapy , Whipple Disease/immunology
16.
Trans R Soc Trop Med Hyg ; 108(4): 181-2, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24488980

ABSTRACT

Among many other factors, malaria plays a major causative role of anaemia globally. The mechanisms leading to anaemia in the course of malaria are extremely diverse, involving immunological factors that act differently according to age and malaria epidemiology. The malaria-attributable fraction of anaemia may then differ in different settings. While tremendous efforts are being made to control malaria, the availability of a simple and reliable biomarker of impact is of the upmost importance. Promising data are accumulating that Hb levels could be used as a proxy of malaria even in hypo-endemic areas, even if many grey areas still deserve research efforts.


Subject(s)
Anemia/etiology , Malaria/complications , Anemia/diagnosis , Humans , Malaria/prevention & control
17.
Curr HIV Res ; 5(3): 349-53, 2007 May.
Article in English | MEDLINE | ID: mdl-17504177

ABSTRACT

Rifampicin (RIF) decreases serum concentrations of several antiretroviral drugs. We carried out a prospective, comparative study to define efavirenz (EFV) pharmacokinetics in 16 cases and 13 controls. Cases were HIV and tuberculosis (TB) co-infected adults assuming RIF 600 mg once daily and EFV 800 mg once daily. Patients on EFV at standard 600 mg dose without RIF were taken as controls. EFV levels in plasma were assayed by high-performance liquid chromatography (HLPC) predose (C(trough)) and at 1, 2, 3, 4, 5, 6, 8, 10, 11, 12, 13, 14, 16, 18, 22 and 24 hours post-dose, and pharmacokinetic parameters were determined by non-compartmental methods. Among cases, 81% were males, mean age was 37 years, 50% were Caucasians, mean weight was 64 kg, mean CD4 cell counts and log HIV RNA copies were 160/microl and 5.2 /microl, respectively. Cases had a significantly higher Cl/F/kg if compared with controls (0.269 +/- 0.12 versus 0.167 + 0.05 L/h/kg, p<0.01). Otherwise, dose-dependent pharmacokinetic parameters of EFV were similar between cases and controls. Interindividual variability was consistently higher among TB cases compared to controls for all considered parameters. All cases completed combined treatment and no increased EFV toxicity was observed. These results suggest that a dose of 800 mg of EFV in association with rifampicin may be appropriate for patients of weight > 60 kg in Europe. Therapeutic drug monitoring may be beneficial for patients on combination therapy with RIF.


Subject(s)
Anti-HIV Agents/pharmacokinetics , Antibiotics, Antitubercular/pharmacokinetics , Benzoxazines/pharmacokinetics , HIV Infections/drug therapy , Rifampin/pharmacokinetics , Tuberculosis/drug therapy , Adult , Alkynes , Anti-HIV Agents/administration & dosage , Benzoxazines/administration & dosage , Biological Availability , Cyclopropanes , Drug Interactions , Female , HIV Infections/complications , Humans , Male , Prospective Studies , Tuberculosis/complications
19.
Rev Iberoam Micol ; 22(3): 169-71, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16309355

ABSTRACT

In the past the Italian soil was considered as a low-endemic pabulum for H. capsulatum var. capsulatum and only few autochthonous cases of histoplasmosis were reported in Italy, especially in the Po valley. The aim of the paper was to evaluate this possibility by reviewing the literature and providing our own personal data. Four additional cases of histoplasmosis were observed during 1999-2003 in AIDS immigrant or in Italian citizens, and in travellers to endemic areas. One of the AIDS patients was an autochthonous case of histoplasmosis. The Italian literature was reviewed. Recent cases and literature data confirm the possible autochthonous presence of histoplasmosis in Italy, especially in the Northern regions.


Subject(s)
Histoplasmosis/epidemiology , AIDS-Related Opportunistic Infections/epidemiology , AIDS-Related Opportunistic Infections/microbiology , Adult , Cote d'Ivoire/ethnology , Emigration and Immigration , Female , Humans , Italy/epidemiology , Latin America , Male , Middle Aged , Nicaragua , Pakistan , Retrospective Studies , Tanzania , Travel
SELECTION OF CITATIONS
SEARCH DETAIL
...